IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.31
0.00 (0.00%)
Apr 30, 2025, 10:22 AM - Market open

IGM Biosciences Statistics

Share Statistics

IGM Biosciences has 59.78M shares outstanding. The number of shares has increased by 1.27% in one year.

Shares Outstanding 59.78M
Shares Change (YoY) 1.27%
Shares Change (QoQ) 0.52%
Owned by Institutions (%) 35.74%
Shares Floating 28.42M
Failed to Deliver (FTD) Shares 5.07K
FTD / Avg. Volume 2.34%

Short Selling Information

The latest short interest is 894.06K, so 1.5% of the outstanding shares have been sold short.

Short Interest 894.06K
Short % of Shares Out 1.5%
Short % of Float 5.76%
Short Ratio (days to cover) 5

Valuation Ratios

The PE ratio is -1.89 and the forward PE ratio is -2.2. IGM Biosciences's PEG ratio is 0.06.

PE Ratio -1.89
Forward PE -2.2
PS Ratio 138.02
Forward PS 2.9
PB Ratio 7.68
P/FCF Ratio -2.33
PEG Ratio 0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for IGM Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.94.

Current Ratio 5.14
Quick Ratio 5.14
Debt / Equity 0.94
Debt / EBITDA -0.22
Debt / FCF -0.28
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $17.98K
Profits Per Employee $-1.31M
Employee Count 149
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -86.4% in the last 52 weeks. The beta is 0.57, so IGM Biosciences's price volatility has been higher than the market average.

Beta 0.57
52-Week Price Change -86.4%
50-Day Moving Average 1.27
200-Day Moving Average 7.71
Relative Strength Index (RSI) 51.37
Average Volume (20 Days) 216.99K

Income Statement

In the last 12 months, IGM Biosciences had revenue of 2.68M and earned -195.79M in profits. Earnings per share was -3.24.

Revenue 2.68M
Gross Profit 2.68M
Operating Income -208.58M
Net Income -195.79M
EBITDA -208.58M
EBIT -208.58M
Earnings Per Share (EPS) -3.24
Full Income Statement

Balance Sheet

The company has 26.5M in cash and 45.19M in debt, giving a net cash position of -18.69M.

Cash & Cash Equivalents 26.5M
Total Debt 45.19M
Net Cash -18.69M
Retained Earnings -1.02B
Total Assets 265.71M
Working Capital 155.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -153M and capital expenditures -5.85M, giving a free cash flow of -158.85M.

Operating Cash Flow -153M
Capital Expenditures -5.85M
Free Cash Flow -158.85M
FCF Per Share -2.62
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -7785.74% and -7308.51%.

Gross Margin 100%
Operating Margin -7785.74%
Pretax Margin -7308.51%
Profit Margin -7308.51%
EBITDA Margin -7785.74%
EBIT Margin -7785.74%
FCF Margin -5929.38%

Dividends & Yields

IGMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for IGMS is $2, which is 52.7% higher than the current price. The consensus rating is "Hold".

Price Target $2
Price Target Difference 52.7%
Analyst Consensus Hold
Analyst Count 8
Stock Forecasts

Scores

Altman Z-Score -7.02
Piotroski F-Score 3